A living systematic review protocol for COVID-19 clinical trial registrations
<p>Since the coronavirus disease 2019 (COVID-19) outbreak was identified in December 2019 in Wuhan, China, a strong response from the research community has been observed with the proliferation of independent clinical trials assessing diagnostic methods, therapeutic and prophylactic strategies...
Main Authors: | Maguire, BJ, Guerin, PJ |
---|---|
Format: | Journal article |
Language: | English |
Published: |
F1000 Research Ltd
2020
|
Similar Items
-
Baseline results of a living systematic review for COVID-19 clinical trial registrations
by: Maguire, BJ, et al.
Published: (2020) -
The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions
by: McLean, ARD, et al.
Published: (2022) -
Chemoprophlaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations
by: Manoharan, L, et al.
Published: (2021) -
What are the long-term symptoms and complications of COVID-19: A protocol for a living systematic review
by: Michelen, M, et al.
Published: (2020) -
What are the long-term symptoms and complications of COVID-19: a protocol for a living systematic review
by: Michelen, M, et al.
Published: (2020)